Search the Newsreel

Bicara Therapeutics (BCAX) Is Down 13.5% After Leadership Overhaul And ESOP Shelf Filing - Has The Bull Case Changed?

Bicara Therapeutics (BCAX) has seen a 13.5% drop following a significant leadership reshuffle, including new executives for CEO, CFO, COO, Chief Business Officer, and Chief Legal Officer roles. This overhaul, coupled with a wider net loss of US$55.44 million and an ESOP shelf filing …

Fischer Medical Ventures Share: Medical Devices Worth Buying?

Does Halozyme’s Raised 2026 Revenue Outlook And Aggressive Buybacks Change The Bull Case For HALO?

Halozyme Therapeutics reported strong Q2 2026 results with increased revenue and net income, alongside significant share repurchases of 13.45 million shares for $750 million. The company also raised its 2026 revenue guidance to between $1.84 billion and $1.91 billion, signaling management's confidence. This performance …

Latham Advises Frazier Life Sciences on Private Placement Financing With Fulcrum Slate Merger

Latham & Watkins LLP advised Frazier Life Sciences on an oversubscribed US$245 million private placement financing. This financing supports the merger between Fulcrum Therapeutics, Inc. (Nasdaq: FULC) and Slate Medicines, Inc., an all-stock transaction. The combined company will focus on advancing Slate’s pipeline, including …

Koh Brothers Eco Engineering faces up to $57.6m legal dispute liabilities

Form 8K Fulcrum Therapeutics Inc For: 17 August By Investing.com

This article reports that Fulcrum Therapeutics Inc. filed a Form 8K on August 17. The filing is brief and does not provide further details within the article text. The content also includes market data and related news headlines.

Matador Resources, Oceaneering, Northern Oil and Gas, and Talos Energy Shares Skyrocket, What You Need To Know

What Happened? A number of stocks jumped in the afternoon session after Iran ruled out extending a 60-day memorandum of understanding with the United States. The June 17 memorandum was meant to reopen Hormuz while the two sides negotiated a nuclear deal within 60 …

Are MITT, ARX, HHS, FULC Obtaining Fair Deals for their Shareholders?

Halper Sadeh LLC, an investor rights law firm, is investigating TPG Mortgage Investment Trust, Inc. (MITT), Accelerant Holdings (ARX), Harte Hanks, Inc. (HHS), and Fulcrum Therapeutics, Inc. (FULC) for potential violations of federal securities laws and/or breaches of fiduciary duties related to their proposed …

DiaMedica (DMAC) Q2 2026 Earnings Call Transcript

Neumora Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

This document from Neumora Therapeutics is a Notice of Proposed Sale of Securities pursuant to Rule 144. It indicates that the company is reporting on the intended sale of restricted or control securities as required by SEC regulations.

Tenaya Therapeutics, Inc. SEC Filing (Aug 18, 2026)

What's Going On With Briacell Therapeutics Corp Stock Monday?

CAPR Stock Alert: Capricor Therapeutics, Inc. (CAPR)

Avalo Therapeutics (AVTX) insider lines up $98.7K stock sale

Avalo Therapeutics insider Mittie Doyle has filed a Form 144, indicating an intention to sell 5,037 shares of common stock on August 17, 2026, valued at $98,674.83, tied to the exercise of stock options. The filing also details several prior Rule 10b5-1 sales of …

Stoke Therapeutics’ Dravet Trial Tops Enrollment Target With Zero Dropouts

Stoke Therapeutics announced that its Phase III EMPEROR study for zorevunersen in Dravet syndrome has surpassed its enrollment target with 162 patients and zero dropouts, attributing the high retention to the drug's tolerability and an open-label extension. The trial's primary endpoint is seizure reduction …

Archer Aviation (ACHR) Q2 2026 Earnings Call Transcript

Coherent Corp. Earnings Call Signals AI-Fueled Surge

Coherent Corp.'s latest earnings call highlighted record revenue of $7.12 billion for fiscal 2026, driven by surging data center and communications demand, with EPS climbing 59%. Despite strong growth and long-term agreements providing visibility, the company faces near-term challenges including Indium Phosphide production constraints, …

Form 8K Coherus BioSciences Inc For: 17 August By Investing.com

This article reports on a Form 8K filing by Coherus BioSciences Inc for August 17. The brief piece primarily serves as an announcement for the filing, linking to Reuters for more details. It also includes general market data and other popular news headlines.

Medicenna Therapeutics Corp (MDNAF) Q3 2026 Earnings Report - Results, Call & Slides

Joana Goncalves Sells 7,000 Shares of Oruka Therapeutics (NASDAQ:ORKA) Stock

Structure Therapeutics (GPCR) As August Updates Reframe The Case For Its Valuation

Rashi Peripherals sets Sept 9 AGM; seeks ₹5,000 crore borrowing limit

Coherent Corp (COHR) Stock Up 7.8% but GF Value Says Overvalued -- GF Score: 76/100

Coherent Corp (COHR) stock surged 7.8% on August 17, 2026, reaching $351.22, and has seen a 90.3% year-to-date increase. Despite this growth, GuruFocus's GF Value™ indicates the stock is 262.0% overvalued at $97.01, and the company is currently unprofitable and cash-flow negative. While its …

Axsome Therapeutics (AXSM) After Mixed Earnings What Does The Valuation Narrative Say

Axsome Therapeutics (AXSM) is under scrutiny after reporting mixed Q2 2026 earnings, with increased revenue but also wider net losses. Despite a recent pullback, the stock shows strong long-term momentum, and analysts currently value it at $282.51 per share, suggesting it is undervalued compared …

Norfolk Southern Corp. stock underperforms Monday when compared to competitors despite daily gains

Norfolk Southern Corp. (NSC) stock advanced 2.01% on Monday, closing at $341.12, despite an overall poor trading session for the broader market. The S&P 500 Index and Dow Jones Industrial Average both saw declines. NSC's stock ended the day 4.87% below its 52-week high …

Halozyme (NASDAQ: HALO) insider lines up new stock sale after recent disposals

Halozyme Therapeutics insider Helen Torley has filed a Form 144, indicating a proposed sale of 240,000 shares of common stock with an aggregate market value of $23,678,400. This follows previous sales by Torley totaling 51,923 shares over the past three months, generating over $3.5 …

Scott Bizily plans new 4D Molecular (NASDAQ: FDMT) sale after 10b5-1 stock trades

Scott Bizily plans to sell 6,540 shares of 4D Molecular Therapeutics (NASDAQ: FDMT) on August 17, 2026, following the exercise of stock options. This transaction, processed through Morgan Stanley Smith Barney LLC, has an associated value of $79,722.60. The filing also details three previous …

4D Molecular Therapeutics (NASDAQ: FDMT) legal chief sells 3,270 shares

Scott Bizily, Chief Legal Officer of 4D Molecular Therapeutics (FDMT), sold 3,270 shares of common stock after exercising options. The transactions occurred on August 13 and August 17, 2026, with sales at $12.00 and $12.20 per share, respectively, and were executed under a Rule …

Neumora (NASDAQ: NMRA) to sell 146K shares via Merrill Lynch

Neumora Therapeutics, Inc. has filed a Form 144 notice indicating a proposed sale of 146,706 common shares through Merrill Lynch, valued at approximately $220,135.18. The shares are expected to be sold on or about August 17, 2026, on the NASDAQ. These shares were acquired …

Toll Brothers Announces Model Home Grand Opening at Franklin Ridge Community in Franklin, Tennessee

Toll Brothers, Inc. announced the grand opening of its Liora Transitional model home at Franklin Ridge, a new luxury single-family home community in Franklin, Tennessee. The public is invited to an event on August 20, 2026. The community offers 4-7 bedroom homes starting from …

Heritage Insurance Holdings, Inc. SEC Filing (Aug 17, 2026)

This article details an SEC Form 144 filing by Heritage Insurance Holdings, Inc. (HRTG) on August 17, 2026. The filing indicates a proposed sale of 5,000 shares of common stock with an aggregate market value of $171,250.00 by a person whose securities were acquired …

Heritage Insurance (NYSE: HRTG) plans $342K stock sale from vested awards

Heritage Insurance Holdings, Inc. (NYSE: HRTG) has filed a Form 144 notice for a proposed sale of 10,000 shares of common stock, valued at $341,587.00, through Morgan Stanley Smith Barney LLC Executive Financial Services. These shares are from restricted stock awards that vested in …

Sherwin-Williams Co. stock underperforms Monday when compared to competitors

Shares of Sherwin-Williams Co. (SHW) fell 2.54% on Monday, closing at $349.97, while the broader market also experienced a downturn. The S&P 500 Index declined 0.52% and the Dow Jones Industrial Average fell 0.51%. This marked the second consecutive day of losses for Sherwin-Williams …

Coherent (COHR) Starts Sampling 300mm Silicon Carbide Substrates For AI Infrastructure

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Coherent (NYSE:COHR) has begun customer sampling of its advanced 300mm high thermal conductivity silicon …

Avalo Therapeutics (NASDAQ: AVTX) insider to sell shares

An insider at Avalo Therapeutics (NASDAQ: AVTX) has filed a Form 144 notice to sell 3,749 shares of common stock, valued at $74,762.10, through Morgan Stanley Smith Barney LLC on or after August 17, 2026. The shares include those acquired through option exercises and …

Avalo Therapeutics, Inc. SEC Filing (Aug 17, 2026)

This article reports on an SEC Form 144 filing by Avalo Therapeutics, Inc. (AVTX) on August 17, 2026. The filing details the proposed sale of common stock by an individual through Morgan Stanley Smith Barney LLC, acquired via the exercise of stock options. The …